Pfizer (PFE) Revenue (2009 - 2026)
Pfizer's Revenue was $15.03 billion in Q2 2026, up 2.6% from $14.65 billion a year earlier and up 4.0% from the prior quarter.
Powered by 
Analysis
Pfizer (PFE) Revenue (2009 - 2026) Analysis & Trends
On a trailing twelve-month basis, Pfizer's Revenue was $63.7 billion through Jun 28, 2026, down 0.2% year-over-year; for FY2025, it came in at $62.58 billion, down 1.6% from FY2024.
- Revenue shows a five-year compound annual growth rate of 8.5% (FY2020 to FY2025).
- In earlier years, Revenue was $63.63 billion in FY2024 (+6.8%), $59.55 billion in FY2023 (-41.1%), $101.18 billion in FY2022 (+24.5%) and $81.29 billion in FY2021 (+95.2%).
- Quarterly Revenue has moved between -$62.47 billion (Q4 2022) and $27.74 billion (Q2 2022) over five years.
- Compared with a year earlier, Revenue was higher in four of the last seven quarters, with growth averaging 3.6%.
- The best year-over-year quarter for Revenue over five years was Q3 2021 (growth of 133.9%); the worst was Q2 2023 (a decline of 53.1%).
- Per Business Quant data, PFE's Revenue in the three quarters before Q2 2026 was $14.45 billion (Q1 2026), $17.56 billion (Q4 2025) and $16.65 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 25.31 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 16.99 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 16.61 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 14.41 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 15.38 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 10.05 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 7.80 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 15.03 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 3.33 Bn |
| 10 | Bristol Myers Squibb | 127.55 Bn | 78.82 Bn | 9.25 Bn | 12.97 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 28, 2026 | 15.03 Bn |
| Mar 29, 2026 | 14.45 Bn |
| Dec 31, 2025 | 17.56 Bn |
| Sep 28, 2025 | 16.65 Bn |
| Jun 29, 2025 | 14.65 Bn |
| Mar 30, 2025 | 13.72 Bn |
| Dec 31, 2024 | 17.76 Bn |
| Sep 29, 2024 | 17.70 Bn |
| Jun 30, 2024 | 13.28 Bn |
| Mar 31, 2024 | 14.88 Bn |
| Dec 31, 2023 | 14.57 Bn |
| Jul 2, 2023 | 13.01 Bn |
| Apr 2, 2023 | 18.49 Bn |
| Sep 30, 2022 | -62.47 Bn |
| Jul 3, 2022 | 27.74 Bn |
| Apr 3, 2022 | 25.66 Bn |
| Oct 3, 2021 | 24.04 Bn |
| Jul 4, 2021 | 18.90 Bn |
| Apr 4, 2021 | 14.52 Bn |
| Dec 31, 2020 | 11.43 Bn |
API Access
Pfizer Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=PFE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "PFE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=PFE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();